Atnaujinkite slapukų nuostatas

Cellular Engineering and Cellular Therapies: Proceedings of the Twenty-Seventh International Symposium on Blood Transfusion, Groningen, Organized by the Sanquin Division Blood Bank North-East, Groningen 2004 ed. [Kietas viršelis]

  • Formatas: Hardback, 223 pages, aukštis x plotis: 235x155 mm, weight: 1140 g, XIV, 223 p., 1 Hardback
  • Serija: Developments in Hematology and Immunology 38
  • Išleidimo metai: 31-Oct-2003
  • Leidėjas: Springer-Verlag New York Inc.
  • ISBN-10: 1402017138
  • ISBN-13: 9781402017131
Kitos knygos pagal šią temą:
  • Formatas: Hardback, 223 pages, aukštis x plotis: 235x155 mm, weight: 1140 g, XIV, 223 p., 1 Hardback
  • Serija: Developments in Hematology and Immunology 38
  • Išleidimo metai: 31-Oct-2003
  • Leidėjas: Springer-Verlag New York Inc.
  • ISBN-10: 1402017138
  • ISBN-13: 9781402017131
Kitos knygos pagal šią temą:
Papers from a recent symposium look at academic and blood bank aspects of the emerging science and application of cellular engineering and cellular therapies. Grouped in sections on defining the field, processing, quality, and clinical experiences, papers examine areas related to the potential of stem cell transplantation to rescue the failing liver, biological modification of lymphocytes on auto- and allo-immune diseases, cell harvest and purification technology, factors controlling the expansion and maturation of hematopoietic progenitor cells, cell processing for gene and cell therapy protocols, dendritic cell vaccination, and reconstituting T cell immunity following hematopoietic stem cell transplantation. Annotation ©2004 Book News, Inc., Portland, OR (booknews.com)

Transfusion Medicine is a rapidly developing field of science which increasingly needs the bridging between fundamental biomedical research and applied research - this bridging is also recognised as translational research. The field of engineering of potential cells for therapeutic application does not only cover gene therapy, but also covers the manipulation of cellular characteristics and functional capacities. Harvest, preservation and manipulation of specific cells circulating in the peripheral blood extend beyond the conventional technologies. Where the procurement of human blood cells has been the field of expertise of the conventional blood bank, this extension should be regarded as a development of the field into a new direction. This new direction needs a change in philosophy, approach and expertise where an integrated collaborative attitude with the academic world is of paramount importance.This book provides the complete gamma of aspects, both academic and blood banking, of this fascinating new field of science and clinical application. It illustrates the potential possibilities and future opportunities to add new therapeutic directions to clinical medicine.
Moderators and Speakers ix
Foreword xiii
I. DEFINING THE FIELD
Cellular Engineering and Cellular Therapies -- an Overview
3(8)
L.F.M.H. de Leij
Gene Therapy 2002: A New Start
11(10)
N.H. Mulder
Stem Cells: Potential, Selection and Plasticity
21(10)
G. de Haan
The Potential of Stem Cell Transplantation to Rescue the Failing Liver
31(14)
P.L.M. Jansen
Discussion
35(10)
II. PROCESSING ASPECTS
The New Regulatory Environment for Cellular Therapy Products: Challenges for Academic-Based Manufacturing Facilities
45(10)
E.J. Read
Biological Modification of Lymphocytes on Auto- and Allo-Immune Diseases
55(14)
J.W. Semple
Cell Harvest and Purification Technology -- State of the Art and Future Development
69(12)
P. Law
Cell Manipulation and Engineering -- State of the Art and Future Developments
81(8)
S.J. Noga
Cellular Immunotherapy -- Towards Direct DC Activation for Licence to Kill
89(22)
F.A. Ossendorp
Discussion
95(16)
III. QUALITY ASPECTS
From Research to Clinical Application - the Quality Concept
111(8)
P.H. Roddie
Factors Controlling Expansion and Maturation of Haematopoietic Progenitor Cells
119(14)
A.L. Drayer
Cell Processing for Gene and Cell Therapy Protocols: Limitations and Opportunities!
133(20)
I. Slaper-Cortenbach
Discussion
139(14)
IV. CLINICAL EXPERIENCES AND PROSPECT FOR TREATMENT
State of the Art in Dendritic Cell Vaccination
153(8)
J. de Vries
Reconstituting T Cell Immunity Following Hematopoietic Stem Cell Transplantation
161(10)
S.R. Solomon
State of the Art in Gene Therapy
171(18)
H.J. Haisma
New Horizons in Cellular Therapies
189(14)
P. Rebulla
Cellular Engineering and Cellular Therapies -- Transfusion Medicine and the Academic World
203(12)
C.Th. Smit Sibinga
Discussion
207(8)
Index 215